Compare IRWD & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | TITN |
|---|---|---|
| Founded | 1998 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 586.6M | 543.1M |
| IPO Year | 2009 | 2007 |
| Metric | IRWD | TITN |
|---|---|---|
| Price | $3.47 | $23.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $6.10 | ★ $25.25 |
| AVG Volume (30 Days) | ★ 1.6M | 168.1K |
| Earning Date | 11-09-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1400.00 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | $298,276,000.00 | ★ $2,427,107,000.00 |
| Revenue This Year | $59.19 | N/A |
| Revenue Next Year | $4.80 | $3.29 |
| P/E Ratio | $6.46 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $1.47 | $13.21 |
| 52 Week High | $5.78 | $26.90 |
| Indicator | IRWD | TITN |
|---|---|---|
| Relative Strength Index (RSI) | 37.03 | 51.23 |
| Support Level | $3.04 | $22.38 |
| Resistance Level | $3.96 | $25.48 |
| Average True Range (ATR) | 0.18 | 1.19 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 11.97 | 39.25 |
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.